These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 11252025

  • 21. Effects of chronic haloperidol and clozapine treatment on neurotensin and c-fos mRNA in rat neostriatal subregions.
    Merchant KM, Dobie DJ, Filloux FM, Totzke M, Aravagiri M, Dorsa DM.
    J Pharmacol Exp Ther; 1994 Oct; 271(1):460-71. PubMed ID: 7965747
    [Abstract] [Full Text] [Related]

  • 22. Dopamine D3 receptors are not involved in the induction of c-fos mRNA by neuroleptic drugs: comparison of the dopamine D3 receptor antagonist GR103691 with typical and atypical neuroleptics.
    Hurley MJ, Stubbs CM, Jenner P, Marsden CD.
    Eur J Pharmacol; 1996 Dec 30; 318(2-3):283-93. PubMed ID: 9016916
    [Abstract] [Full Text] [Related]

  • 23. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
    Bruins Slot LA, Lestienne F, Grevoz-Barret C, Newman-Tancredi A, Cussac D.
    Eur J Pharmacol; 2009 Oct 12; 620(1-3):27-35. PubMed ID: 19695244
    [Abstract] [Full Text] [Related]

  • 24. Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease.
    Ryoo HL, Pierrotti D, Joyce JN.
    Mov Disord; 1998 Sep 12; 13(5):788-97. PubMed ID: 9756147
    [Abstract] [Full Text] [Related]

  • 25. Spatial and temporal profile of haloperidol-induced immediate-early gene expression and phosphoCREB binding in the dorsal and ventral striatum of amphetamine-sensitized rats.
    Hsieh HC, Li HY, Lin MY, Chiou YF, Lin SY, Wong CH, Chen JC.
    Synapse; 2002 Sep 15; 45(4):230-44. PubMed ID: 12125044
    [Abstract] [Full Text] [Related]

  • 26. Dopamine D3 as well as D2 receptor ligands attenuate the cue-induced cocaine-seeking in a relapse model in rats.
    Gál K, Gyertyán I.
    Drug Alcohol Depend; 2006 Jan 04; 81(1):63-70. PubMed ID: 16005579
    [Abstract] [Full Text] [Related]

  • 27. Lack of dopamine supersensitivity in rats after chronic administration of blonanserin: Comparison with haloperidol.
    Hashimoto T, Baba S, Ikeda H, Oda Y, Hashimoto K, Shimizu I.
    Eur J Pharmacol; 2018 Jul 05; 830():26-32. PubMed ID: 29684390
    [Abstract] [Full Text] [Related]

  • 28. Effect of combined treatment with imipramine and amantadine on the central dopamine D2 and D3 receptors in rats.
    Rogóz Z, Dlaboga D, Dziedzicka-Wasylewska M.
    J Physiol Pharmacol; 2003 Jun 05; 54(2):257-70. PubMed ID: 12832726
    [Abstract] [Full Text] [Related]

  • 29. Antiparkinson concentrations of pramipexole and PHNO occupy dopamine D2(high) and D3(high) receptors.
    Seeman P, Ko F, Willeit M, McCormick P, Ginovart N.
    Synapse; 2005 Nov 05; 58(2):122-8. PubMed ID: 16088951
    [Abstract] [Full Text] [Related]

  • 30. Active versus passive cocaine administration: differences in the neuroadaptive changes in the brain dopaminergic system.
    Stefański R, Ziółkowska B, Kuśmider M, Mierzejewski P, Wyszogrodzka E, Kołomańska P, Dziedzicka-Wasylewska M, Przewłocki R, Kostowski W.
    Brain Res; 2007 Jul 09; 1157():1-10. PubMed ID: 17544385
    [Abstract] [Full Text] [Related]

  • 31. Upregulation of dopamine D3, not D2, receptors correlates with tardive dyskinesia in a primate model.
    Mahmoudi S, Lévesque D, Blanchet PJ.
    Mov Disord; 2014 Aug 09; 29(9):1125-33. PubMed ID: 24838395
    [Abstract] [Full Text] [Related]

  • 32. Enhanced apomorphine sensitivity and increased binding of dopamine D2 receptors in nucleus accumbens in prepubertal rats after neonatal blockade of the dopamine D3 receptors by (+)-S14297.
    Flores-Tochihuitl J, Vargas G, Morales-Medina JC, Rivera G, De La Cruz F, Zamudio S, Flores G.
    Synapse; 2008 Jan 09; 62(1):40-9. PubMed ID: 17957737
    [Abstract] [Full Text] [Related]

  • 33. Persistent spontaneous oral dyskinesias in haloperidol-withdrawn rats neonatally lesioned with 6-hydroxydopamine: absence of an association with the Bmax for [3H]raclopride binding to neostriatal homogenates.
    Huang NY, Kostrzewa RM, Li C, Perry KW, Fuller RW.
    J Pharmacol Exp Ther; 1997 Jan 09; 280(1):268-76. PubMed ID: 8996206
    [Abstract] [Full Text] [Related]

  • 34. Dopamine D3 receptor antisense administration reduces basal c-fos and NGFI-B mRNA levels in the rat forebrain.
    Tremblay M, Rouillard C, Lévesque D.
    Synapse; 1999 Apr 09; 32(1):51-7. PubMed ID: 10188638
    [Abstract] [Full Text] [Related]

  • 35. Differential visualization of dopamine D2 and D3 receptor sites in rat brain. A comparative study using in situ hybridization histochemistry and ligand binding autoradiography.
    Landwehrmeyer B, Mengod G, Palacios JM.
    Eur J Neurosci; 1993 Feb 01; 5(2):145-53. PubMed ID: 8261096
    [Abstract] [Full Text] [Related]

  • 36. Withdrawal from continuous or intermittent cocaine administration: changes in D2 receptor function.
    King GR, Ellinwood EH, Silvia C, Joyner CM, Xue Z, Caron MG, Lee TH.
    J Pharmacol Exp Ther; 1994 May 01; 269(2):743-9. PubMed ID: 8182540
    [Abstract] [Full Text] [Related]

  • 37. Changes in the pattern of brain-derived neurotrophic factor immunoreactivity in the rat brain after acute and subchronic haloperidol treatment.
    Dawson NM, Hamid EH, Egan MF, Meredith GE.
    Synapse; 2001 Jan 01; 39(1):70-81. PubMed ID: 11071712
    [Abstract] [Full Text] [Related]

  • 38. Dopamine-D1 and -D2 receptors differentially regulate synapsin II expression in the rat brain.
    Chong VZ, Skoblenick K, Morin F, Xu Y, Mishra RK.
    Neuroscience; 2006 Jan 01; 138(2):587-99. PubMed ID: 16413126
    [Abstract] [Full Text] [Related]

  • 39. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
    Florijn WJ, Tarazi FI, Creese I.
    J Pharmacol Exp Ther; 1997 Feb 01; 280(2):561-9. PubMed ID: 9023264
    [Abstract] [Full Text] [Related]

  • 40. Effect of repeated treatment with mirtazapine on the central dopaminergic D2/D3 receptors.
    Rogóz Z, Wróbel A, Dlaboga D, Dziedzicka-Wasylewska M.
    Pol J Pharmacol; 2002 Feb 01; 54(4):381-9. PubMed ID: 12523492
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.